ArticleOne health (Amsterdam, Netherlands)2022
How are large-scale One Health initiatives targeting infectious diseases and antimicrobial resistance evaluated? A scoping review.
Article in One health (Amsterdam, Netherlands), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Issues and principles for legitimate and meaningful One Health monitoring.International journal of public health · 2026Article
- A multisectoral effort against Crimean-Congo hemorrhagic fever: Towards One Health approach implementation in the Balkans and Black Sea region.One health (Amsterdam, Netherlands) · 2025Article
- Economic methods and spatial scales in One Health: Results from a scoping review.One health (Amsterdam, Netherlands) · 2025Review
- Knowledge, attitude, and husbandry practices on zoonoses prevention and control among livestock farmers in Thiruvarur, Tamil Nadu, India: a cross-sectional study.BMC veterinary research · 2025Article
- One Health interventions and challenges under rural African smallholder farmer settings: A scoping review.One health (Amsterdam, Netherlands) · 2025Review
- Knowledge, attitude, and practice of One Health and zoonotic diseases among multisectoral collaborators in Bhutan: Results from a nationwide survey.PLOS global public health · 2025Article
- Learning from over ten years of implementing the One Health approach in the Democratic Republic of Congo: A qualitative study.One health (Amsterdam, Netherlands) · 2024Article
- Governance of the wildlife trade and the prevention of emerging zoonoses: a mixed methods network analysis of transnational organisations, silos, and power dynamics.Globalization and health · 2024Article
- Attitudes of South Korean consumers toward the prudent use of antimicrobials in livestock animals.One health (Amsterdam, Netherlands) · 2024Article
- Navigating One Health in research-for-development: Reflections on the design and implementation of the CGIAR Initiative on One Health.One health (Amsterdam, Netherlands) · 2024Article
- Scaling up One Health: A network analysis in Lao PDR.One health (Amsterdam, Netherlands) · 2024Article
- One health adoption within prevention, preparedness and response to health threats: Highlights from a scoping review.One health (Amsterdam, Netherlands) · 2023Article
- Intersectoral collaboration in a One Health approach: Lessons learned from a country-level simulation exercise.One health (Amsterdam, Netherlands) · 2023Article
- The approaching pilot for One Health governance index.Infectious diseases of poverty · 2023Article
- The Characterization and Beta-Lactam Resistance of Staphylococcal Community Recovered from Raw Bovine Milk.Antibiotics (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While One Health initiatives are gaining in popularity, it is unclear if and how they are evaluated when implementation at scale is intended. The main purpose of this scoping review was to describe how One Health initiatives targeting infectious diseases and antimicrobial resistance at a large scale are evaluated. Secondary objectives included identifying the main facilitators and barriers to the implementation and success of these initiatives, and how their impacts were assessed. Twenty-three studies evaluating One Health initiatives were eligible. Most studies included the human (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.